The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany

Background: Real-word evidence from diverse data sources is increasingly important in terms of generating rapid insights to effectively manage patient populations, especially during major public health disruptions such as the ongoing COVID-19 pandemic. Patients with chronic and inflammatory diseases...

Full description

Bibliographic Details
Main Authors: Jonathan Orschiedt, Elizabeth Jacyshyn-Owen, Maria Kahn, Sven Jansen, Natalie Joschko, Markus Eberl, Sebastian Schneeweiss, Benjamin Friedrich, Tjalf Ziemssen
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332222015189